What catatonia can tell us about “top-down modulation”: a neuropsychiatric hypothesis

G Northoff - Behavioral and brain sciences, 2002 - cambridge.org
Differential diagnosis of motor symptoms, for example, akinesia, may be difficult in clinical
neuropsychiatry. Symptoms may be either of neurologic origin, for example, Parkinson's …

Social cognition in euthymic bipolar disorder: Systematic review and meta‐analytic approach

C Samame, DJ Martino… - Acta Psychiatrica …, 2012 - Wiley Online Library
Samamé C, Martino DJ, Strejilevich SA. Social cognition in euthymic bipolar disorder:
systematic review and meta‐analytic approach. Objective: Deficits in social cognition have …

GHB: a new and novel drug of abuse

KL Nicholson, RL Balster - Drug and alcohol dependence, 2001 - Elsevier
There has been increasing attention in the United States to problems of abuse of gamma-
hydroxybutyrate (GHB), with some evidence for problems in other parts of the world as well …

[HTML][HTML] The predictive validity of the rat self-administration model for abuse liability

EC O'Connor, K Chapman, P Butler… - … & Biobehavioral Reviews, 2011 - Elsevier
The self-administration model is the primary non-clinical approach for assessing the
reinforcing properties of novel compounds. Given the now frequent use of rats in self …

Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence

GM Keating - Clinical Drug Investigation, 2014 - Springer
A liquid formulation of sodium oxybate (Alcover®), the sodium salt of γ-hydroxybutyric acid
(GHB), is approved in Italy and Austria for use in alcohol withdrawal syndrome and for the …

γ-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness

D Pardi, J Black - CNS drugs, 2006 - Springer
Abstract γ-Hydroxybutyrate (GHB) is an endogenous short chain fatty acid and a, mostly oral,
pharmacological compound that has been utilised in a variety of ways. Endogenously, GHB …

[PDF][PDF] Driving Under the Infl uence of Non-Alcohol Drugs-An Update. Part II: Experimental Studies

MC Strand, H Gjerde, J Mørland - Forensic …, 2016 - cdn-nrspp-s3-aus.s3.ap-southeast-2 …
Experimental studies on the impairing effects of drugs of relevance to driving-related
performance published between 1998 and 2015 were reviewed. Studies with on-the-road …

Gamma-hydroxybutyrate and ethanol effects and interactions in humans

D Thai, JE Dyer, NL Benowitz… - Journal of clinical …, 2006 - journals.lww.com
Background: Gamma-hydroxybutyrate (GHB) is a common drug of abuse that can produce
serious toxicity, particularly when used with other sedatives. We examined the individual …

Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB)

HR Sumnall, K Woolfall, S Edwards, JC Cole… - Drug and alcohol …, 2008 - Elsevier
Self-reported use of γ-hydroxybutyrate (GHB) among clubbers has increased over the last
decade, and is often reported in the scientific literature in association with negative events …

Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome

FP Busardo, C Kyriakou, S Napoletano… - European review for …, 2015 - iris.uniroma1.it
Gamma-hydroxybutyrate (GHB) is a short chain fatty acid endogenously produced within the
central nervous system (CNS) and acts as a precursor and metabolite of the inhibitory …